Vaxfab Enterprises Ltd Reports Financial Results for Q/FY Ending March 31, 2026; Auditors Issue Disclaimer of Opinion

Vaxfab Enterprises Ltd Reports Financial Results for Q/FY Ending March 31, 2026; Auditors Issue Disclaimer of Opinion​

Vaxfab Enterprises Ltd has released its audited financial results for the quarter and fiscal year ended on March 31, 2026. The company's standalone and consolidated statements detail revenue, expenses, and profit performance across the reporting periods. However, the statutory auditors have issued a Disclaimer of Opinion on both the standalone and consolidated financial results due to certain qualifications noted during the audit process.

The company’s results for the quarter ending March 31, 2026, show Total Revenue of 9959.59 in lakhs, while the corresponding full year-to-date figures stand at 9410.75 in lakhs. The standalone financial results show a profit before tax of 517.47 lakhs for the quarter and 363.80 lakhs for the period to date.

Standalone Financial Performance​

Key highlights from the audited standalone financial statements include:

Consolidated Financial Performance​

The consolidated financial results for the year ending March 31, 2026, show Total Revenue of 13675.13 lakhs and Total Expenses of 13986.76 lakhs. The Net Profit/(Loss) before tax for the quarter was (311.62), while for the year-to-date figures it stood at (311.62).

Basis for Audit Qualifications​

In relation to both the standalone and consolidated financial statements, auditors have issued a Disclaimer of Opinion. The primary reasons for this qualification relate to internal record keeping and documentation across various aspects of the business operations:

Standalone Financial Results Qualification:
The audit noted that prior management inadequately maintained records pertaining to sales, purchases, inventory, trade receivables, and trade payables. Furthermore, balance confirmations from debtors and creditors were unavailable. Other qualifications included the fact that unsecured loans had been granted and received without formal loan agreements or obtaining balance confirmations in some instances. Additionally, the company did not maintain requisite records to identify and classify creditors under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act).

Consolidated Financial Results Qualification:
Similarly, the audit of the consolidated results noted that certain records from earlier periods were improperly handed over by previous management of entities included in the consolidation. The qualification is based on the inability to obtain sufficient appropriate audit evidence regarding compliance with recognition, measurement, presentation and disclosure requirements under Indian Accounting Standards (Ind AS).

In line with the financial reporting requirements for the consolidated results, one subsidiary company and one subsidiary LLP were included whose financial statements/information had not been audited by the auditors.

Stock Price Movement​

As of 14:56, shares of Vaxfab Enterprises Ltd. are ticking up by 2.54%, currently trading at ₹61.70. The company's stock traded within the day, establishing a range between a high of ₹61.70 and a low of ₹60.00.